About this trial
Undiagnosed COPD represents a significant issue in terms of morbidity and mortality, as nearly 50% of smokers with chronic respiratory symptoms also experience impaired quality of life and acute events similar to COPD exacerbations. We aim to study the prevalence of airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Participating to the prevention campain "Mai Poumons 2026" on 09 Mai 2026
Disqualifiers
Contre-indication to perform a spirometry : hemoptysy, pneumothorax, myocardal infarction <1month, thoracic anevrism, recent ophtalmologic, abdominal or thoracic surgery
Unable to perform a spirometry (understanding, coordination)
Patient under legal protection
Patient pregnant or breasting
Trial design
Treatments tested in this trial
- Spirometry
Treatment groups
Locations
Sponsors and collaborators
Centre Hospitalier de la côte Basque
Lead sponsor